Breathe Well Live Well
|
Genetic Testing For Asthma Reveals That Some Children Can Outgrow The …
Medical Daily Asthma is a respiratory condition that affects seven million children and 18 million adults. The disease affects the lungs and swells the airways, making breathing difficult and causing coughing, wheezing, and shortness of breath. It can even be … |
View full post on asthma – Google News
Wall Street Journal |
Forget Lab Rats: Testing Asthma Drugs on a Microchip
Wall Street Journal Company scientists want to see whether these "lungs on a chip" can help them better understand the biology behind asthma and identify promising candidates for medicines, says Don Nicholson, who oversees Merck's respiratory drug research. If efforts … |
View full post on asthma – Google News
Wall Street Journal- India |
Forget Lab Rats: Testing Asthma Drugs on a Microchip
Wall Street Journal- India Company scientists want to see whether these "lungs on a chip" can help them better understand the biology behind asthma and identify promising candidates for medicines, says Don Nicholson, who oversees Merck's respiratory drug research. If efforts … |
View full post on asthma – Google News
|
Mold Testing in Homes Utilizing Advanced DNA Testing Techniques
WebWire (press release) Exposure to elevated levels of mold can trigger asthma episodes in sensitive individuals, allergic reactions and even cause fungal infections in people with compromised immune systems. In fact, the US Environmental Protection Agency (EPA) recommends … |
View full post on asthma – Google News
|
Aerocrine: South Carolina Adopts Positive Coverage of Aerocrine's FeNo Testing …
Business Wire (press release) “FeNO testing is a significant advancement in managing the patient with asthma. Since the publication of the American Thoracic Guideline on FeNO, this test should be standard of care in every clinic managing asthma patients. South Carolina adopts positive coverage of Aerocrine's FeNO testing in … |
View full post on asthma – Google News
|
South Carolina adopts positive coverage of Aerocrine's FeNO testing in …
CisionWire (press release) Physicians use FeNO to assess eosinophilic airway inflammation, the primary underlying abnormality that affects the airways of individuals who have asthma. NIOX MINO is the only product of its kind currently on the market for assessing FeNO. |
View full post on asthma – Google News
|
Mississippi's Medicaid program adds coverage for Aerocrine's FeNO testing in …
EON: Enhanced Online News (press release) Asthma is a chronic inflammatory disease of the airways that affects more than 300 million people worldwide, many of whom are children. FeNO is a marker of the underlying airway inflammation associated with asthma, and Aerocrine has developed a method … |
View full post on asthma – Google News
|
Mississippi's Medicaid program adds coverage for Aerocrine's FeNO testing in …
MarketWatch (press release) Asthma is a chronic inflammatory disease of the airways that affects more than 300 million people worldwide, many of whom are children. FeNO is a marker of the underlying airway inflammation associated with asthma, and Aerocrine has developed a method … |
View full post on asthma – Google News
Allergy Testing in Childhood: Using Allergen-Specific IgE Tests.
Pediatrics. 2011 Dec 26;
Authors: Sicherer SH, Wood RA,
Abstract
A variety of triggers can induce common pediatric allergic diseases which include asthma, allergic rhinitis, atopic dermatitis, food allergy, and anaphylaxis. Allergy testing serves to confirm an allergic trigger suspected on the basis of history. Tests for allergen-specific immunoglobulin E (IgE) are performed by in vitro assays or skin tests. The tests are excellent for identifying a sensitized state in which allergen-specific IgE is present, and may identify triggers to be eliminated and help guide immunotherapy treatment. However, a positive test result does not always equate with clinical allergy. Newer enzymatic assays based on anti-IgE antibodies have supplanted the radioallergosorbent test (RAST). This clinical report focuses on allergen-specific IgE testing, emphasizing that the medical history and knowledge of disease characteristics are crucial for rational test selection and interpretation.
PMID: 22201146 [PubMed – as supplied by publisher]
View full post on pubmed: asthma
|
New breakthroughs in testing for asthma
WNDU-TV 24 million Americans experience these symptoms when asthma attacks. The chronic respiratory disease is obvious in some, but other patients suffer a long time, while doctors struggle to figure out their problem. Now, a new test is helping undiagnosed … |
View full post on asthma – Google News